Histogen (HSTO) Competitors $0.03 +0.00 (+10.38%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends HSTO vs. PTIX, SNOA, ATXI, CHRO, ONCO, PRTG, PCSA, ARTL, GENE, and SBFMShould you be buying Histogen stock or one of its competitors? The main competitors of Histogen include Protagenic Therapeutics (PTIX), Sonoma Pharmaceuticals (SNOA), Avenue Therapeutics (ATXI), Chromocell Therapeutics (CHRO), Onconetix (ONCO), Portage Biotech (PRTG), Processa Pharmaceuticals (PCSA), Artelo Biosciences (ARTL), Genetic Technologies (GENE), and Sunshine Biopharma (SBFM). These companies are all part of the "pharmaceutical products" industry. Histogen vs. Protagenic Therapeutics Sonoma Pharmaceuticals Avenue Therapeutics Chromocell Therapeutics Onconetix Portage Biotech Processa Pharmaceuticals Artelo Biosciences Genetic Technologies Sunshine Biopharma Protagenic Therapeutics (NASDAQ:PTIX) and Histogen (NASDAQ:HSTO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, community ranking, earnings, institutional ownership, analyst recommendations, risk and profitability. Does the media favor PTIX or HSTO? In the previous week, Protagenic Therapeutics' average media sentiment score of 0.00 equaled Histogen'saverage media sentiment score. Company Overall Sentiment Protagenic Therapeutics Neutral Histogen Neutral Does the MarketBeat Community favor PTIX or HSTO? Histogen received 7 more outperform votes than Protagenic Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformProtagenic TherapeuticsN/AN/AHistogenOutperform Votes758.33% Underperform Votes541.67% Which has preferable valuation and earnings, PTIX or HSTO? Protagenic Therapeutics has higher earnings, but lower revenue than Histogen. Protagenic Therapeutics is trading at a lower price-to-earnings ratio than Histogen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProtagenic TherapeuticsN/AN/A-$5M-$1.27-0.47Histogen$19K6.21-$10.62M-$2.81-0.01 Do insiders & institutionals hold more shares of PTIX or HSTO? 8.0% of Protagenic Therapeutics shares are held by institutional investors. 37.0% of Protagenic Therapeutics shares are held by insiders. Comparatively, 3.3% of Histogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, PTIX or HSTO? Protagenic Therapeutics has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500. Comparatively, Histogen has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Is PTIX or HSTO more profitable? Histogen's return on equity of 0.00% beat Protagenic Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Protagenic TherapeuticsN/A -308.97% -228.73% Histogen N/A N/A N/A SummaryHistogen beats Protagenic Therapeutics on 6 of the 10 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Histogen News Delivered to You Automatically Sign up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSTO vs. The Competition Export to ExcelMetricHistogenPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$118,000.00$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-0.0110.5990.0517.18Price / Sales6.21195.801,117.14116.99Price / CashN/A57.1643.0437.86Price / Book0.015.094.784.78Net Income-$10.62M$151.83M$120.31M$225.60M7 Day PerformanceN/A-2.13%-1.92%-1.23%1 Month PerformanceN/A-3.10%11.51%3.36%1 Year PerformanceN/A11.54%30.61%16.60% Histogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSTOHistogenN/A$0.03+10.4%N/A-92.2%$118,000.00$19,000.00-0.017Gap UpPTIXProtagenic Therapeutics0.8395 of 5 stars$0.54+8.1%N/A-28.0%$3.64MN/A-0.391Positive NewsGap UpSNOASonoma Pharmaceuticals0.5865 of 5 stars$2.70+1.1%N/A+1,658.0%$3.62M$12.73M0.00180ATXIAvenue Therapeutics1.52 of 5 stars$1.75-2.8%N/A-83.6%$3.59MN/A0.104CHROChromocell TherapeuticsN/A$0.59+1.4%N/AN/A$3.58MN/A0.004Gap UpONCOOnconetix0.142 of 5 stars$0.43+5.8%N/AN/A$3.53M$1.87M0.0012Gap DownPRTGPortage Biotech1.3568 of 5 stars$3.31+10.3%N/A-74.3%$3.48MN/A-0.076Gap UpPCSAProcessa Pharmaceuticals3.039 of 5 stars$1.05-5.4%$6.00+471.2%-89.9%$3.43MN/A-0.3320News CoverageGap DownARTLArtelo Biosciences2.0681 of 5 stars$1.06-4.5%$5.50+418.9%-27.1%$3.42MN/A-0.395News CoverageGENEGenetic TechnologiesN/A$0.77-1.9%N/AN/A$3.37M$7.66M0.0050News CoverageSBFMSunshine Biopharma1.3507 of 5 stars$2.71-1.5%$15.00+453.5%-88.9%$3.31M$24.09M-0.023Gap Down Related Companies and Tools Related Companies Protagenic Therapeutics Competitors Sonoma Pharmaceuticals Competitors Avenue Therapeutics Competitors Chromocell Therapeutics Competitors Onconetix Competitors Portage Biotech Competitors Processa Pharmaceuticals Competitors Artelo Biosciences Competitors Genetic Technologies Competitors Sunshine Biopharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSTO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSTO Stock Alerts